Skip to main content

Akesogen, London Genetics Team on Pharmacogenetic Services

NEW YORK (GenomeWeb News) – Akesogen, a Norcross, Ga.-based genomic and biorepository services firm, and London Genetics International today announced that they will collaborate on offering pharmacogentic services to the biopharmaceutical industry.

Among the services provided by the firms will be biomarker and assay development. Financial and other terms were not disclosed.

"Our expertise in pharmacogenetic strategy development combined with a professional genomics services company that operates to CLIA standards will make this strategic alliance beneficial to both companies as it will increase our scope of possible services into the Americas with highly qualified and service oriented scientists," Elizabeth Foot, VP of personalised medicine and nutrition for London Genetics, said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.